Intellia Therapeutics(NTLA) - 2021 Q3 - Earnings Call Transcript
Intellia Therapeutics(NTLA)2021-11-05 01:41
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2021 Results Conference Call November 4, 2021 8:00 AM ET Company Participants Ian Karp - SVP, IR and Corporate Communications Dr. John Leonard - CEO Dr. David Lebwohl - Chief Medical Officer Dr. Laura Sepp-Lorenzino - Chief Scientific Officer Glenn Goddard - CFO Conference Call Participants Maury Raycroft - Jefferies Joon Lee - Truist Securities Rick Bienkowski - SVB Leerink Xiaobin Gao - Barclays Luca Issi - RBC Liisa Bayko - Evercore ISI Yanan Zhu - Wells Fargo ...